Recently, the scientific breakthrough, clustered regularly interspaced short palindromic repeats (CRISPR)-Cas (CRISPR associated protein) system has gained momentum for genome editing in plants
According to FDA-approved labeling and clinical trial data, the following side effects occur most commonly: Gastrointestinal Effects: Nausea (affecting 1544% of patients, with higher rates at Wegovy doses) [3] [4] Diarrhea (reported in 830% of patients) Vomiting (524% incidence) Constipation (occurring in 324% of patients) Abdominal pain (520% of patients) These gastrointestinal symptoms typically emerge during dose escalation and often diminish with continued therapy as physiological adaptation occurs
Why does my weekly trend change so much?+ Short-term trends are affected by water, digestion, sodium, sleep, bowel changes, training, travel, illness, stress, and timing
biomaterial-based immunotherapies
These side effects may be more common after starting therapy and after a dose increase
Indications: Body Mass Index (BMI) of 30 or Higher (Obesity)